Nyxoah SA Net Profit Margin 2021-2025 | NYXH

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Nyxoah SA net profit margin from 2021 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Nyxoah SA net profit margin from 2021 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$46.1B
Hims & Hers Health (HIMS)	$11.6B
Doximity (DOCS)	$11.6B
Tempus AI (TEM)	$10B
IRhythm Technologies (IRTC)	$4.4B
Inspire Medical Systems (INSP)	$3.8B
Hinge Health (HNGE)	$3.7B
Privia Health (PRVA)	$2.5B
Enovis (ENOV)	$1.8B
Phreesia (PHR)	$1.6B
Schrodinger (SDGR)	$1.6B
10x Genomics (TXG)	$1.5B
Clover Health Investments (CLOV)	$1.5B
Azenta (AZTA)	$1.5B
Evolent Health (EVH)	$1.3B
Omnicell (OMCL)	$1.3B
Claritev (CTEV)	$763M
Fulgent Genetics (FLGT)	$582M
Veradigm (MDRX)	$547M
Standard BioTools (LAB)	$475M
Butterfly Network (BFLY)	$450M
Talkspace (TALK)	$430M
Outset Medical (OM)	$333M
TruBridge (TBRG)	$329M
Health Catalyst (HCAT)	$269M
SOPHiA GENETICS SA (SOPH)	$231M
CapsoVision (CV)	$203M
KORU Medical Systems (KRMD)	$149M
Zepp Health (ZEPP)	$139M
American Well (AMWL)	$126M